Grail’s Liquid Biopsy Can Detect Numerous Deadly Cancer Types Early

01 Apr 2020

Grail announced results from an initial validation study that showed its early-detection blood test could identify 12 of the deadliest cancers with a low rate of false-positive results.

Close up on microscope with Beaker and Test Tube laboratory out of focus. Chemistry and science research concept background.

Liquid biopsy start-up Grail Inc. announced that in a study of almost 6,700 participants, its blood test could detect more than 50 types of cancer, including 12 very dangerous types of cancers, with a low false-positive rate, indicating it could be useful for screening patients.

The sub-study from the company’s 15,000-patient Circulating Cell-free Genome Atlas (CCGA) study analyzed cell-free DNA from normal and cancerous...